Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 27, 2023 8-K
8-K Feb 24, 2023 8-K
4 Jan 5, 2023 OWNERSHIP DOCUMENT
8-K Jan 3, 2023 8-K
SC 13G/A Jan 3, 2023 SC 13G/A
8-K Dec 27, 2022 8-K
8-K Dec 21, 2022 8-K
10-Q Nov 14, 2022 10-Q
8-K Nov 14, 2022 8-K
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
4 Sep 9, 2022 OWNERSHIP DOCUMENT
8-K Sep 1, 2022 8-K
10-Q Aug 15, 2022 10-Q
8-K Aug 15, 2022 8-K
S-8 Jul 14, 2022 FORM S-8
4 Jul 5, 2022 OWNERSHIP DOCUMENT
3 Jul 5, 2022 OWNERSHIP DOCUMENT
← Newer Page 6 of 38 · 935 filings Older →